IBM delivered a quarter that should have been a victory lap. Revenue of $15.92 billion crushed the $15.62 billion consensus, while adjusted EPS of $1.91 handily topped the $1.81 expected. Yet shares dropped 6% in after-hours trading. The reason? Management refused to budge on its full-year outlook.
This is the expectations gap that haunts value investors. IBM has now shed roughly 15% of its value since the start of 2026, a brutal stretch during which the S&P 500 gained 4%. The market is pricing in stagnation-or worse-while the business is accelerating. Software revenue climbed 11%, z17 mainframe revenue surged 51%, and free cash flow reached $2.22 billion. The fundamentals are moving in the right direction with real momentum.
CFO Jim Kavanaugh's explanation was straightforward, if frustrating for bulls: "I don't think we've ever raised guidance in a first quarter," he told analysts. "We believe the company should be a prudent operator." The company reiterated targets for over 5% constant-currency revenue growth and a $1 billion free cash flow gain. These aren't modest goals-they're aggressive by legacy tech standards. But the market isn't rewarding execution; it's punishing the lack of forward guidance.
Here's the asymmetry: IBM has room to beat its own targets, but limited room to raise them. The stock is already pricing in disappointment. If the company delivers on its 2026 outlook, the market will have to recalibrate-or the gap between price and performance will only widen.
The Growth Engine: Software, Mainframe, and Infrastructure
While the market fixated on guidance, the business delivered something more important: real momentum across every key segment. Software revenue hit $7.05 billion, up 11% year over year-more than double the 5% constant-currency target management set for the full year. This isn't a fluke. Red Hat grew 13%, data and automation both posted double-digit gains, and the segment's 8% constant-currency expansion shows the AI tailwind is real and accelerating.
Infrastructure tells an even more striking story. Revenue jumped 15% to $3.33 billion, driven by a 51% surge in Z mainframe hardware revenue. The z17 model is pacing ahead of earlier product cycles, a rare occurrence for a platform that typically turns over slowly. This isn't just a bump-it's evidence that IBM's infrastructure stack is regaining traction at exactly the moment enterprises are scaling AI workloads.
Profitability is moving in tandem. Operating pre-tax margin expanded 140 basis points to 13.4%, with management targeting roughly 1% expansion for the full year. That target now looks conservative given the Q1 run rate. Free cash flow reached $2.22 billion, up $258 million year over year, putting IBM on track to exceed its $1 billion annual gain target. The company declared its 31st consecutive year of raised quarterly dividends-a quiet signal of financial flexibility that the market seems to have overlooked.
The asymmetry here is striking. IBM is delivering growth that exceeds its own guidance, yet the stock trades as if stagnation is the base case. Software is expanding at more than twice the rate management flagged as achievable. Infrastructure is surging on mainframe strength that few analysts anticipated. Free cash flow is tracking well above the annual target with nine months remaining.
The market is pricing in a company that's holding steady. The reality is a business accelerating faster than the guidance suggests. When the segments that matter most-software and infrastructure-are both growing at double-digit rates, the question isn't whether IBM can beat its outlook. It's whether the market will recalibrate before the gap becomes untenable.
The Guidance Question: Why Not Raise?
IBM's decision to hold its full-year targets steady despite a strong Q1 beat raises an obvious question: is this caution, or is it strategic positioning? The answer matters because it determines whether the current stock price represents a discount or simply reflects management's disciplined communication style.
The company reiterated targets for more than 5 percent constant currency revenue growth and an increase of about $1 billion in year-over-year free cash flow-targets it has now delivered on in the first quarter. Software revenue alone climbed 11%, more than double the 5% constant-currency bar. Infrastructure surged 15%, driven by a 51% z17 mainframe hardware jump. Free cash flow hit $2.22 billion, more than double the annual target with nine months remaining.
Yet management refused to budge. CFO Jim Kavanaugh's explanation was straightforward: "I don't think we've ever raised guidance in a first quarter," he told analysts. "We believe the company should be a prudent operator."
That principle creates an interesting asymmetry. IBM is delivering results that exceed its own guidance, but the company hasn't signaled what happens when it surpasses those targets. The guidance acts as a floor, not a ceiling-and the market is pricing the stock as if the ceiling is equally distant.
Two developments suggest the upside case is underappreciated. First, the $11 billion Confluent deal closed mid-March, adding data-streaming capabilities that could accelerate software revenue. The acquisition hasn't altered margin targets-management still expects roughly 1% operating pre-tax margin expansion-but it has expanded the addressable market for IBM's software portfolio. That optionality isn't reflected in the current guidance.
Second, mainframe AI inferencing is emerging as a monetization vector that management has only begun to articulate. The z17 model is pacing ahead of earlier product cycles, with 51% surge in Z mainframe hardware revenue. This isn't just a hardware refresh-it's enterprises scaling AI workloads on IBM's infrastructure stack. The first-year placement value for z17 already exceeded prior programs by over $1 billion, and new MIPS (the mainframe's capacity metric) have grown over 100% for four consecutive quarters.
The market is pricing in a company that's holding steady. But the business has at least three vectors-software acceleration, Confluent integration, and mainframe AI monetization-that could drive results beyond current guidance. When a company delivers double-digit growth in its two largest segments while maintaining disciplined communication, the question isn't whether it can beat its outlook. It's whether the market will recalibrate before the gap becomes untenable.
IBM's "prudent operator" stance may be the smartest play here. By setting a floor and then clearing it, the company creates repeated opportunities to surprise to the upside-without the risk of missing forward-looking targets. For a stock trading at a discount to its own momentum, that's a strategic advantage, not a limitation.
Valuation and the Asymmetric Setup
The market has punished IBM for not raising guidance, but the stock's underperformance tells a clearer story. IBM has shed roughly 15% of its value since the start of 2026, while the S&P 500 gained 4%-a gap of roughly 19 percentage points. This is extraordinary for a company delivering 9% revenue growth and beating consensus on both top and bottom lines. The market is pricing in stagnation while the business accelerates.
The dividend announcement reinforces management's conviction. IBM just raised its quarterly payout for the 31st straight year, with the June 10 payment confirming confidence in cash generation. This isn't a company signaling trouble-it's one that's consistently returned capital while investing for growth. The market seems to have overlooked this quiet signal of financial flexibility.
So what closes the gap? Three catalysts stand out. First, any indication in Q2 that mainframe AI momentum is accelerating-the z17 surge and 100%+ MIPS growth for four consecutive quarters suggest the trajectory is real. Second, Red Hat and Confluent integration delivering incremental revenue-the $11 billion acquisition closed mid-March and has expanded the addressable market. Third, management signaling willingness to raise guidance-CFO Jim Kavanaugh's "prudent operator" stance has created a floor that IBM has already cleared.
The asymmetry is striking. IBM is delivering results that exceed its own guidance-software at 11%, infrastructure at 15%, free cash flow more than double the annual target-yet trades as if stagnation is the base case. The stock prices in disappointment while the business accelerates. That disconnect won't last. When a company clears its own guidance by wide margins, the market eventually has to recalibrate. The question isn't whether the gap closes, but whether investors positioned now capture the asymmetry before it does.